Alnylam Pharmaceuticals
ALNY
#443
Rank
NZ$90.97 B
Marketcap
NZ$688.59
Share price
1.00%
Change (1 day)
62.58%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company